MedTech News
.................... by Andrew Celentano
Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device
BEIJING, Aug. 11, 2026 /PRNewswire/ — Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) (“Datasea” or the “Company”), a technology company focused on acoustic high-tech and AI multimodal digital solutions, today announced that Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd. (“Shuhai Jingwei”), the Company’s variable interest entity in China, has completed establishment registration and device listing with the U.S. Food and Drug Administration (“FDA”) for its NeuroVibe Biofeedback System, including products NV-02 and NV-03.
AI framework decodes how brain regions talk to one another
For decades, neuroscientists have been able to record which parts of the brain show increased electrical activity during a behavior, such as when we form a memory or make a decision. But scientists haven’t been able to determine how those regions are communicating with and influencing one another, nor identify which regions serve as the main orchestrators.
Wearable microneedle patch empowers conventional ultrasound for continuous glucose monitoring
Long-term diabetes management requires continuous blood glucose monitoring to detect abnormalities early and intervene in time. However, conventional fingertip blood sampling is both painful and inconvenient, while most continuous glucose monitoring (CGM) products currently available on the market rely on biological enzymes—requiring regular replacement, incurring higher costs and demanding stringent storage conditions.
An origami-inspired implant could monitor health from beneath the skin
The skin is the body’s largest organ. It is a protective shield that keeps harmful pathogens out and vital fluids inside. These very properties make it a tough engineering challenge to design wearable health sensors because many internal chemical signals cannot easily pass through it.
Detection of optic nerve inflammation enables earlier multiple sclerosis diagnoses
Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. An early and accurate diagnosis is crucial for improving the effectiveness of treatment and reducing nerve damage.
New miniature microscope allows scientists to watch and control brain cells during natural movement
Researchers at the University of Colorado Anschutz and the University of Colorado Boulder have developed a miniature microscope that allows scientists to observe and activate individual brain cells during natural movement.
Sleep could help identify people at risk of developing Alzheimer’s disease at an earlier stage
What if certain signs of the disease were to manifest subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège.
Elevation Spine lands FDA clearance for expandable interbody fusion system
Elevation’s FDA clearance for Saber-XA follows the agency’s clearance of its Saber-C AVIA cervical fixation device in July.